BCL-2 expression in the human placenta and its correlation with fibrin deposits

被引:31
作者
Marzioni, D [1 ]
Mühlhauser, J
Crescimanno, C
Banita, M
Pierleoni, C
Castellucci, M
机构
[1] Univ Ancona, Inst Normal Human Morphol, I-60020 Ancona, Italy
[2] IDI, Lab Vasc Pathol, Rome, Italy
[3] Rhein Westfal TH Aachen, Dept Anat, Aachen, Germany
[4] Univ Verona, Inst Anat & Histol, I-37100 Verona, Italy
[5] Univ Turin, Dept Med Sci, Novara, Italy
关键词
BCL-2; fibrin; immunohistochemistry; microscopy; placenta;
D O I
10.1093/humrep/13.6.1717
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The human placenta performs numerous functions during its limited lifespan and its survival is a necessary prerequisite for fetal nutrition, even in unfavourable conditions. BCL-2 is a proto-oncogene implicated in the regulation of cell death and survival without affecting cell proliferation. An extracellular matrix molecule involved in the reparative and degenerative processes in the human placenta is fibrin. We have analysed by immunohistochemistry the expression of BCL-2 and correlated it with fibrin deposits in placental tissues. In first and third trimester placentas BCL-2 was expressed in the syncytiotrophoblast. Only a few mesenchymal villi (first trimester) or terminal villi (third trimester) showed no staining in the syncytiotrophoblast. Villous cytotrophoblast, mesenchymal cells of the villous cores and extravillous cytotrophoblast of cell columns and cell islands were all negative for BCL-2. BCL-2 expression was enhanced in the syncytiotrophoblast overlying subtrophoblastic fibrin deposits. However, discontinuities and/or variations in intensity of BCL-2 expression characterized not only the villi showing perivillous fibrinoid but also those villi with a massive presence of fibrinoid in their cores. These data suggest that BCL-2 may be necessary for the preservation of the placenta during gestation as well as for the reparative processes of the trophoblast.
引用
收藏
页码:1717 / 1722
页数:6
相关论文
共 44 条
[31]   THE EXTRACELLULAR-MATRIX AS A CELL-SURVIVAL FACTOR [J].
MEREDITH, JE ;
FAZELI, B ;
SCHWARTZ, MA .
MOLECULAR BIOLOGY OF THE CELL, 1993, 4 (09) :953-961
[32]   DIFFERENTIATION AND PROLIFERATION PATTERNS IN HUMAN TROPHOBLAST REVEALED BY C-ERBB-2 ONCOGENE PRODUCT AND EGF-R [J].
MUHLHAUSER, J ;
CRESCIMANNO, C ;
KAUFMANN, P ;
HOFLER, H ;
ZACCHEO, D ;
CASTELLUCCI, M .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1993, 41 (02) :165-173
[33]   DIFFERENTIATION OF HUMAN TROPHOBLAST POPULATIONS INVOLVES ALTERATIONS IN CYTOKERATIN PATTERNS [J].
MUHLHAUSER, J ;
CRESCIMANNO, C ;
KASPER, M ;
ZACCHEO, D ;
CASTELLUCCI, M .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1995, 43 (06) :579-589
[34]  
NELSON DM, 1990, AM J PATHOL, V136, P855
[35]   Apoptotic changes occur in syncytiotrophoblast of human placental villi where fibrin type fibrinoid is deposited at discontinuities in the villous trophoblast [J].
Nelson, DM .
PLACENTA, 1996, 17 (07) :387-391
[36]  
PEZZELLA F, 1990, AM J PATHOL, V137, P225
[37]  
RICHART R, 1961, P SOC EXP BIOL MED, V106, P829
[38]   DIFFERENTIATION-DEPENDENT EXPRESSION OF THE BCL-2 PROTOONCOGENE IN THE HUMAN TROPHOBLAST LINEAGE [J].
SAKURAGI, N ;
MATSUO, H ;
COUKOS, G ;
FURTH, EE ;
BRONNER, MP ;
VANARSDALE, CM ;
KRAJEWSKY, S ;
REED, JC ;
STRAUSS, JF .
JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION, 1994, 1 (02) :164-172
[39]  
THIET MS, 1995, J OBSTET, V172, P272
[40]  
TOTH F, 1973, ACTA MORPHOL HUNG, V21, P89